Investment banking to pharma corp dev?

Hi all, I'm going into an MBA program and was wondering what the path would look like if I were to want to do investment banking for a few years before recruiting for corp dev roles in pharma companies like Eli Lilly or Merck? It seems like the PE recruiting route is far more common for investment bankers... is there any corporate development recruiting or are these fully networking based opportunities?

5 Comments
 

Bump - Incoming Biopharma IB Analyst very interested in taking this path

 
Most Helpful

Banking to pharma corp dev is a solid move if you're in a healthcare coverage group. The financial modeling and deal execution skills transfer well, but you'll need to show genuine interest in the science and industry dynamics.
A few things that help make the transition:
Your deal experience matters most. If you've worked on healthcare M&A or pharma financing deals, that's your story. If not, you'll need to explain why you're pivoting and show you understand the space.
Pharma values people who can evaluate science and commercial potential, not just run DCFs. If you're coming from pure finance, expect to spend time learning therapeutic areas, regulatory pathways, and pipeline risk.
Timing wise, 2 to 3 years in banking is enough to make the move. Longer than that and you risk being seen as too finance focused. Target larger pharma with active BD teams or biotech hubs where deal flow is consistent.
I work with people making this transition. If you want to discuss positioning yourself for these roles, feel free to DM.

https://pharmacoach.carrd.co/
 

Hi, undergrad here

How useful would a Life Sciences degree be for healthcare/life sciences/biopharma IB? Someone can learn the industry without spending too much effort, but learning the raw science, as I see it, can be sort of an unfuckable quality. Is my view flawed at all?

 

Anonymous Monkey:

Hi, undergrad here

How useful would a Life Sciences degree be for healthcare/life sciences/biopharma IB? Someone can learn the industry without spending too much effort, but learning the raw science, as I see it, can be sort of an unfuckable quality. Is my view flawed at all?


Your view is mostly right. The science background helps you understand pipelines, clinical data, and drug mechanisms faster than peers coming from pure finance. It's harder to fake and gives you credibility with clients.
That said, you still need strong finance fundamentals. The science gets you in the door and makes you better at the job, but you need to know how to model and execute deals. Best combo is life sciences degree plus solid finance coursework or internship. Note, each shop may have a different view on this as some places swing more to one side.
Feel free to DM if you want to discuss further.

https://pharmacoach.carrd.co/
 

A sint nam id sint aliquam animi dignissimos. Et asperiores quia est pariatur dolorum. Doloremque blanditiis reprehenderit iusto qui assumenda nemo. Animi non vel illo aut labore culpa dignissimos voluptas. Sit quia ratione sint voluptatem aut molestiae debitis.

Inventore quis amet blanditiis laudantium error vitae. Labore quia voluptatem culpa. Beatae magni illum nobis eos ipsa maxime dolorem. Veniam sunt ab labore ipsam. Temporibus maiores non nemo quam. Saepe et cum nesciunt saepe sit aut.

Ea culpa debitis corrupti animi autem deleniti. Ipsam repudiandae doloremque atque adipisci occaecati.

Omnis suscipit ut libero. Nulla autem similique sed blanditiis sint aut. Ut doloribus culpa aut aliquam odio. Dolorem nihil labore ab est.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
dosk17's picture
dosk17
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”